Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-23-016391
Filing Date
2023-03-06
Accepted
2023-03-06 17:07:59
Documents
1
Period of Report
2023-02-24

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 9528
  Complete submission text file 0001209191-23-016391.txt   10940
Mailing Address 7000 MARINA BLVD BRISBANE CA 94005
Business Address 7000 MARINA BLVD BRISBANE CA 94005 5109706000
SANGAMO THERAPEUTICS, INC (Issuer) CIK: 0001001233 (see all company filings)

EIN.: 680359556 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 7000 MARINA BLVD BRISBANE CA 94005
Business Address
Fontenot Jason D. (Reporting) CIK: 0001851761 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-30171 | Film No.: 23709821